Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
12341 | 913 | 33.4 | 64% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
103 | 3 | O GLCNACYLATION//O GLCNAC TRANSFERASE//O GLCNACASE | 73436 |
1876 | 2 | RIBOSOME INACTIVATING PROTEIN//RICIN//TRICHOSANTHIN | 6016 |
12341 | 1 | VISCUM ALBUM//MISTLETOE LECTIN//MISTLETOE | 913 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | VISCUM ALBUM | authKW | 2835142 | 13% | 74% | 115 |
2 | MISTLETOE LECTIN | authKW | 2088795 | 8% | 87% | 72 |
3 | MISTLETOE | authKW | 1652301 | 15% | 37% | 133 |
4 | MISTLETOE EXTRACT | authKW | 1288266 | 5% | 90% | 43 |
5 | KREBSFOR HERDECKE | address | 803931 | 3% | 96% | 25 |
6 | VISCUM ALBUM L | authKW | 716631 | 3% | 71% | 30 |
7 | ISCADOR R | authKW | 568541 | 2% | 100% | 17 |
8 | KOREAN MISTLETOE | authKW | 548774 | 2% | 86% | 19 |
9 | VISCUM COLORATUM | authKW | 442632 | 2% | 88% | 15 |
10 | ISCADOR | authKW | 403710 | 1% | 93% | 13 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Integrative & Complementary Medicine | 11279 | 14% | 0% | 124 |
2 | Chemistry, Medicinal | 3444 | 19% | 0% | 170 |
3 | Pharmacology & Pharmacy | 1806 | 27% | 0% | 250 |
4 | Oncology | 1794 | 24% | 0% | 221 |
5 | Plant Sciences | 191 | 8% | 0% | 72 |
6 | Biochemistry & Molecular Biology | 83 | 13% | 0% | 115 |
7 | Immunology | 71 | 6% | 0% | 56 |
8 | Medicine, Research & Experimental | 62 | 4% | 0% | 39 |
9 | Biophysics | 59 | 4% | 0% | 37 |
10 | Medical Laboratory Technology | 54 | 2% | 0% | 14 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | KREBSFOR HERDECKE | 803931 | 3% | 96% | 25 |
2 | COMMUNAL HOSP | 401323 | 1% | 100% | 12 |
3 | PL IMMUNOL | 293703 | 3% | 33% | 27 |
4 | COMMUNAL HOSP HERDECKE | 133774 | 0% | 100% | 4 |
5 | ABT ANGEW IMMUNOL | 100331 | 0% | 100% | 3 |
6 | MED SEKT GOETHEANUM | 100331 | 0% | 100% | 3 |
7 | HISCIA | 80257 | 1% | 40% | 6 |
8 | PL EPISTEMOL MED METHODOL | 76439 | 0% | 57% | 4 |
9 | GEMEIN AFTSKRANKENHAUS | 75247 | 0% | 75% | 3 |
10 | OTTO HEUBNER PAEDIAT ADOLESCENT MED OHC | 75247 | 0% | 75% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | FORSCHENDE KOMPLEMENTARMEDIZIN UND KLASSISCHE NATURHEILKUNDE | 36500 | 2% | 7% | 15 |
2 | ARZNEIMITTELFORSCHUNG-DRUG RESEARCH | 14074 | 3% | 2% | 23 |
3 | FORSCHENDE KOMPLEMENTARMEDIZIN | 12156 | 1% | 3% | 13 |
4 | ANTICANCER RESEARCH | 6463 | 7% | 0% | 61 |
5 | NATURAL IMMUNITY | 6005 | 1% | 4% | 5 |
6 | ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH | 3559 | 2% | 1% | 15 |
7 | INTEGRATIVE CANCER THERAPIES | 3503 | 1% | 2% | 7 |
8 | EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE | 2921 | 2% | 0% | 22 |
9 | EUROPEAN JOURNAL OF MEDICAL RESEARCH | 2620 | 1% | 1% | 10 |
10 | ANTI-CANCER DRUGS | 2599 | 2% | 0% | 16 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | VISCUM ALBUM | 2835142 | 13% | 74% | 115 | Search VISCUM+ALBUM | Search VISCUM+ALBUM |
2 | MISTLETOE LECTIN | 2088795 | 8% | 87% | 72 | Search MISTLETOE+LECTIN | Search MISTLETOE+LECTIN |
3 | MISTLETOE | 1652301 | 15% | 37% | 133 | Search MISTLETOE | Search MISTLETOE |
4 | MISTLETOE EXTRACT | 1288266 | 5% | 90% | 43 | Search MISTLETOE+EXTRACT | Search MISTLETOE+EXTRACT |
5 | VISCUM ALBUM L | 716631 | 3% | 71% | 30 | Search VISCUM+ALBUM+L | Search VISCUM+ALBUM+L |
6 | ISCADOR R | 568541 | 2% | 100% | 17 | Search ISCADOR+R | Search ISCADOR+R |
7 | KOREAN MISTLETOE | 548774 | 2% | 86% | 19 | Search KOREAN+MISTLETOE | Search KOREAN+MISTLETOE |
8 | VISCUM COLORATUM | 442632 | 2% | 88% | 15 | Search VISCUM+COLORATUM | Search VISCUM+COLORATUM |
9 | ISCADOR | 403710 | 1% | 93% | 13 | Search ISCADOR | Search ISCADOR |
10 | MISTLETOE THERAPY | 396036 | 2% | 79% | 15 | Search MISTLETOE+THERAPY | Search MISTLETOE+THERAPY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SINGH, BN , SAHA, C , GALUN, D , UPRETI, DK , BAYRY, J , KAVERI, SV , (2016) EUROPEAN VISCUM ALBUM: A POTENT PHYTOTHERAPEUTIC AGENT WITH MULTIFARIOUS PHYTOCHEMICALS, PHARMACOLOGICAL PROPERTIES AND CLINICAL EVIDENCE.RSC ADVANCES. VOL. 6. ISSUE 28. P. 23837 -23857 | 128 | 81% | 2 |
2 | NAZARUK, J , ORLIKOWSKI, P , (2016) PHYTOCHEMICAL PROFILE AND THERAPEUTIC POTENTIAL OF VISCUM ALBUM L..NATURAL PRODUCT RESEARCH. VOL. 30. ISSUE 4. P. 373 -385 | 52 | 93% | 4 |
3 | MARVIBAIGI, M , SUPRIYANTO, E , AMINI, N , MAJID, FAA , JAGANATHAN, SK , (2014) PRECLINICAL AND CLINICAL EFFECTS OF MISTLETOE AGAINST BREAST CANCER.BIOMED RESEARCH INTERNATIONAL. VOL. . ISSUE . P. - | 70 | 85% | 9 |
4 | KIENLE, GS , GLOCKMANN, A , SCHINK, M , KIENE, H , (2009) VISCUM ALBUM L. EXTRACTS IN BREAST AND GYNAECOLOGICAL CANCERS: A SYSTEMATIC REVIEW OF CLINICAL AND PRECLINICAL RESEARCH.JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. VOL. 28. ISSUE . P. - | 78 | 84% | 34 |
5 | HAJTO, T , HOSTANSKA, K , BERKI, T , PALINKAS, L , BOLDIZSAR, F , NAMETH, P , (2005) ONCOPHARMACOLOGICAL PERSPECTIVES OF A PLANT LECTIN (VISCUM ALBUM AGGLUTININ-I): OVERVIEW OF RECENT RESULTS FROM IN VITRO EXPERIMENTS AND IN VIVO ANIMAL MODELS, AND THEIR POSSIBLE RELEVANCE FOR CLINICAL APPLICATIONS.EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. VOL. 2. ISSUE 1. P. 59-67 | 54 | 87% | 32 |
6 | BAR-SELA, G , (2011) WHITE-BERRY MISTLETOE (VISCUM ALBUM L.) AS COMPLEMENTARY TREATMENT IN CANCER: DOES IT HELP?.EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE. VOL. 3. ISSUE 2. P. E55 -E62 | 45 | 88% | 8 |
7 | KIENLE, GS , GRUGEL, R , KIENE, H , (2011) SAFETY OF HIGHER DOSAGES OF VISCUM ALBUM L. IN ANIMALS AND HUMANS - SYSTEMATIC REVIEW OF IMMUNE CHANGES AND SAFETY PARAMETERS.BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE. VOL. 11. ISSUE . P. - | 53 | 73% | 16 |
8 | HOESSLI, DC , AHMAD, I , (2008) MISTLETOE LECTINS: CARBOHYDRATE-SPECIFIC APOPTOSIS INDUCERS AND IMMUNOMODULATORS.CURRENT ORGANIC CHEMISTRY. VOL. 12. ISSUE 11. P. 918-925 | 58 | 73% | 11 |
9 | MELZER, J , ITEN, F , HOSTANSKA, K , SALLER, R , (2009) EFFICACY AND SAFETY OF MISTLETOE PREPARATIONS (VISCUM ALBUM) FOR PATIENTS WITH CANCER DISEASES A SYSTEMATIC REVIEW.FORSCHENDE KOMPLEMENTARMEDIZIN. VOL. 16. ISSUE 4. P. 217-226 | 49 | 74% | 31 |
10 | MANSKY, PJ , WALLERSTEDT, DB , SANNES, TS , STAGL, J , JOHNSON, LL , BLACKMAN, MR , GREM, JL , SWAIN, SM , MONAHAN, BP , (2013) NCCAM/NCI PHASE 1 STUDY OF MISTLETOE EXTRACT AND GEMCITABINE IN PATIENTS WITH ADVANCED SOLID TUMORS.EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. VOL. . ISSUE . P. - | 34 | 100% | 7 |
Classes with closest relation at Level 1 |